{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:07:04Z","timestamp":1773842824186,"version":"3.50.1"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,7,31]]},"DOI":"10.18632\/aging.204876","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T18:54:38Z","timestamp":1690570478000},"page":"6848-6864","source":"Crossref","is-referenced-by-count":10,"title":["The integration of machine learning and multi-omics analysis provides a powerful approach to screen aging-related genes and predict prognosis and immunotherapy efficacy in hepatocellular carcinoma"],"prefix":"10.18632","volume":"15","author":[{"given":"Jiahui","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Huzhou Maternity and Child Health Care Hospital, Huzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Stomatology, First Affiliated Hospital of Huzhou University, Huzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Anhui Medical University, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Anhui Medical University, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinfang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Stomatology, First Affiliated Hospital of Huzhou University, Huzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cnc.2022.04.004","article-title":"Hepatocellular Carcinoma.","volume":"3","author":"Landrum","year":"2022","journal-title":"Crit Care Nurs Clin North Am"},{"key":"3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41575-022-00620-y","article-title":"Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.","volume":"1","author":"Lo","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/cells9061370","article-title":"Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.","volume":"9","author":"Pess\u00f4a","year":"2020","journal-title":"Cells"},{"key":"5","doi-asserted-by":"publisher","first-page":"bbac291","DOI":"10.1093\/bib\/bbac291","article-title":"Immune infiltration and clinical significance analyses of the coagulation-related genes in hepatocellular carcinoma.","volume":"2","author":"Jin","year":"2022","journal-title":"Brief Bioinform"},{"key":"6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12957-021-02176-8","article-title":"LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c.","volume":"1","author":"Li","year":"2021","journal-title":"World J Surg Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"1147301","DOI":"10.3389\/fmolb.2023.1147301","article-title":"Protective effects of isoflavones on alcoholic liver diseases: Computational approaches to investigate the inhibition of ALDH2 with isoflavone analogues.","volume":"1","author":"Kim","year":"2023","journal-title":"Front Mol Biosci"},{"key":"8","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.18632\/aging.102777","article-title":"New landscapes and horizons in hepatocellular carcinoma therapy.","volume":"1","author":"McCubrey","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"9","doi-asserted-by":"publisher","first-page":"188314","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches.","volume":"187","author":"Singh","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.jhep.2015.02.007","article-title":"Liver cancer: Approaching a personalized care.","volume":"6","author":"Mazzaferro","year":"2015","journal-title":"J Hepatol"},{"key":"11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma.","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"12","doi-asserted-by":"publisher","first-page":"792781","DOI":"10.3389\/fimmu.2021.792781","article-title":"Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go.","volume":"1","author":"Jin","year":"2021","journal-title":"Front Immunol"},{"key":"13","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.3390\/ijms22115801","article-title":"Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.","volume":"2","author":"Masaki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"14","doi-asserted-by":"publisher","first-page":"107817","DOI":"10.1016\/j.pharmthera.2021.107817","article-title":"Cellular senescence and hematological malignancies: From pathogenesis to therapeutics.","volume":"22","author":"Zhang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"15","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2017.05.015","article-title":"Senescence in Health and Disease.","volume":"16","author":"Sharpless","year":"2017","journal-title":"Cell"},{"key":"16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular Senescence: Aging, Cancer, and Injury.","volume":"9","author":"Alimonti","year":"2019","journal-title":"Physiol Rev"},{"key":"17","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1158\/0008-5472.CAN-20-0108","article-title":"Cellular Senescence Promotes Skin Carcinogenesis through p38MAPK and p44\/42MAPK Signaling.","volume":"8","author":"Limbad","year":"2020","journal-title":"Cancer Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1172\/JCI72619","article-title":"Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.","volume":"12","author":"David","year":"2014","journal-title":"J Clin Invest"},{"key":"19","doi-asserted-by":"publisher","first-page":"e003069","DOI":"10.1136\/jitc-2021-003069","article-title":"Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma.","volume":"1","author":"Chen","year":"2022","journal-title":"J Immunother Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"1130094","DOI":"10.3389\/fonc.2023.1130094","article-title":"Metabolism-related signatures is correlated with poor prognosis and immune infiltration in hepatocellular carcinomamulti-omics analysis and basic experiments.","volume":"1","author":"Gao","year":"2023","journal-title":"Front Oncol"},{"key":"21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13045-021-01192-1","article-title":"Integrins regulate stemness in solid tumor: an emerging therapeutic target.","volume":"1","author":"Zhang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40425-016-0118-0","article-title":"Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials.","volume":"4","author":"Kroemer","year":"2016","journal-title":"J Immunother Cancer"},{"key":"23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy.","volume":"1","author":"Smyth","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8T cells in cancer and cancer immunotherapy.","volume":"12","author":"G\u00f6genur","year":"2021","journal-title":"Br J Cancer"},{"key":"25","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1172\/JCI81203","article-title":"STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma.","volume":"12","author":"Zhang","year":"2015","journal-title":"J Clin Invest"},{"key":"26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","article-title":"Molecular pathogenesis and systemic therapies for hepatocellular carcinoma.","volume":"3","author":"Villanueva","year":"2022","journal-title":"Nat Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-020-00432-z","article-title":"UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development.","volume":"6","author":"Bian","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/hep.31293","article-title":"PLAGL2-EGFR-HIF-1\/2\u03b1 Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity.","volume":"7","author":"Hossain","year":"2021","journal-title":"Hepatology"},{"key":"29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10038-003-0086-3","article-title":"Association of over-expressed TFDP1 with progression of hepatocellular carcinomas.","volume":"4","author":"Inazawa","year":"2003","journal-title":"J Hum Genet"},{"key":"30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2017.12.021","article-title":"FOXQ1\/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells.","volume":"41","author":"Yu","year":"2018","journal-title":"Cancer Lett"},{"key":"31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.canlet.2011.06.001","article-title":"NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.","volume":"31","author":"Zhou","year":"2011","journal-title":"Cancer Lett"},{"key":"32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3892\/ol.2022.13608","article-title":"FXR1 promotes proliferation, invasion and migration of hepatocellular carcinomaand","volume":"2","author":"Zhang","year":"2023","journal-title":"Oncol Lett"},{"key":"33","doi-asserted-by":"publisher","first-page":"e1571388","DOI":"10.1080\/2162402X.2019.1571388","article-title":"Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma.","volume":"8","author":"Zhang","year":"2019","journal-title":"Oncoimmunology"},{"key":"34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-020-01222-5","article-title":"Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.","volume":"1","author":"Ke","year":"2020","journal-title":"Mol Cancer"},{"key":"35","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3390\/cells9061331","article-title":"Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"key":"36","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.","volume":"30","author":"Lejeune-Dumoulin","year":"2011","journal-title":"JAMA"},{"key":"37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature09807","article-title":"Tumour evolution inferred by single-cell sequencing.","volume":"47","author":"McCombie","year":"2011","journal-title":"Nature"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T00:50:29Z","timestamp":1691283029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":37,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,7,31]]}},"alternative-id":["204876","37517087"],"URL":"https:\/\/doi.org\/10.18632\/aging.204876","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}